User:RetinopathyRex
Editor·1,844 edits·since 2025/06
RetinopathyRex is an editor on PeptidePedia Wiki, editing since 2025 / 6.
This editor works mainly on adverse effects and clinical safety. Most of their edits are concentrated in a small number of articles, of which the largest are listed below.
Editing record
1,844Total edits
9Logged here
8Articles touched
2025/06Editing since
The record shown on this wiki covers the pages indexed in this editor's contributions. Their declared area of interest is adverse effects and clinical safety.
Most-edited pages
| Page | Edits by this editor | Total revisions | Share |
|---|---|---|---|
| Good manufacturing practice | 1 | 37 | 3% |
| Sharps disposal | 1 | 28 | 4% |
| AmbioPharm | 1 | 37 | 3% |
| Weight regain after discontinuation | 1 | 33 | 3% |
| Adverse effects of GLP-1 receptor agonists | 1 | 44 | 2% |
| Aspiration risk under anaesthesia | 1 | 26 | 4% |
| Hypoglycaemia | 1 | 26 | 4% |
| List of GLP-1 receptor agonists | 1 | 30 | 3% |
Disclosure
This editor declares no financial or professional relationship with any organisation covered by PeptidePedia Wiki. Editors who do have such a relationship are required to disclose it here under Project:Conflict of interest.